{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["alcoholic liver disease", "alcoholic liver injury", "biomarkers", "drug induced liver injury", "herb induced liver injury", "liver injury"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "31892250", "DateCompleted": {"Year": "2020", "Month": "05", "Day": "14"}, "DateRevised": {"Year": "2020", "Month": "05", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "12", "Day": "27"}], "Language": ["eng"], "ELocationID": ["212", "10.3390/ijms21010212"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "21", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Dec", "Day": "27"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support.", "Abstract": {"AbstractText": ["Liver injuries caused by the use of exogenous compounds such as drugs, herbs, and alcohol are commonly well diagnosed using laboratory tests, toxin analyses, or eventually reactive intermediates generated during metabolic degradation of the respective chemical in the liver and subject to covalent binding by target proteins. Conditions are somewhat different for idiosyncratic drug induced liver injury (DILI), for which metabolic intermediates as diagnostic aids are rarely available. Although the diagnosis of idiosyncratic DILI can well be established using the validated, liver specific, structured, and quantitative RUCAM (Roussel Uclaf Causality Assessment Method), there is an ongoing search for new diagnostic biomarkers that could assist in and also confirm RUCAM-based DILI diagnoses. With respect to idiosyncratic DILI and following previous regulatory letters of recommendations, selected biomarkers reached the clinical focus, including microRNA-122, microRNA-192, cytokeratin analogues, glutamate dehydrogenase, total HMGB-1 (High Mobility Group Box), and hyperacetylated HMGB-1 proteins. However, the new parameters total HMGB-1, and even more so the acetylated HMGB-1, came under critical scientific fire after misconduct at one of the collaborating partner centers, leading the EMA to recommend no longer the exploratory hyperacetylated HMGB1 isoform biomarkers in clinical studies. The overall promising nature of the recommended biomarkers was considered by EMA as highly dependent on the outstanding results of the now incriminated biomarker hyperacetylated HMGB-1. The EMA therefore correctly decided to officially retract its Letter of Support affecting all biomarkers listed above. New biomarkers are now under heavy scrutiny that will require re-evaluations prior to newly adapted recommendations. With Integrin beta 3 (ITGB3), however, a new diagnostic biomarker may emerge, possibly being drug specific but tested in only 16 patients; due to substantial remaining uncertainties, final recommendations would be premature. In conclusion, most of the currently recommended new biomarkers have lost regulatory support due to scientific misconduct, requiring now innovative approaches and re-evaluation before they can be assimilated into clinical practice."]}, "AuthorList": [{"Identifier": ["0000-0001-8910-1200"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/Main, D-63450 Hanau, Germany."}], "LastName": "Teschke", "ForeName": "Rolf", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/Main, D-63450 Hanau, Germany."}], "LastName": "Eickhoff", "ForeName": "Axel", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Complementary and Integrative Medicine, University of Hawai'i at Manoa, Honolulu, HI 96813, USA."}], "LastName": "Brown", "ForeName": "Amy C", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M2 R1 W6, Canada."}], "LastName": "Neuman", "ForeName": "Manuela G", "Initials": "MG"}, {"Identifier": ["0000-0003-1317-5494"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Occupational, Social and Environmental Medicine, Goethe-University Frankfurt/Main, D-60590 Frankfurt/Main, Germany."}], "LastName": "Schulze", "ForeName": "Johannes", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "3K9958V90M", "NameOfSubstance": "Ethanol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["metabolism"], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ethanol"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Liver"}, {"QualifierName": ["metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Graber M.L., Franklin N., Gordon R. Diagnostic error in Internal Medicine. Arch. Intern. Med. 2005;165:1493\u20131499. doi: 10.1001/archinte.165.13.1493.", "ArticleIdList": ["10.1001/archinte.165.13.1493", "16009864"]}, {"Citation": "Bj\u00f6rnsson E.S. Hepatotoxicity by drugs: The most common implicated agents. Int. J. Mol. Sci. 2016;17:224. doi: 10.3390/ijms17020224.", "ArticleIdList": ["10.3390/ijms17020224", "PMC4783956", "26861310"]}, {"Citation": "Bj\u00f6rnsson E.S., Hoofnagle J.H. Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports. Hepatology. 2016;63:590\u2013603. doi: 10.1002/hep.28323.", "ArticleIdList": ["10.1002/hep.28323", "26517184"]}, {"Citation": "Teschke R. Review. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method. Expert Opin. Drug Metab. Toxicol. 2018;14:1169\u20131187. doi: 10.1080/17425255.2018,1539077.", "ArticleIdList": ["10.1080/17425255.2018,1539077", "30354694"]}, {"Citation": "Sarges P., Steinberg J.M., Lewis J.H. Drug-induced liver injury: Highlights from a review of the 2015 literature. Drug Saf. 2016;39:561\u2013575. doi: 10.1007/s40264-016-0427-8.", "ArticleIdList": ["10.1007/s40264-016-0427-8", "27142208"]}, {"Citation": "Shahbaz O., Mahajan S., Lewis J.H. Highlights of drug-and herb-induced liver injury in the literature from 2016: How best to translate new information into clinical practice? Exp. Opin. Drug Metab. Toxicol. 2017;13:935\u2013951. doi: 10.1080/17425255.2017.1362391.", "ArticleIdList": ["10.1080/17425255.2017.1362391", "28772086"]}, {"Citation": "Real M., Barnhill M.S., Higley C., Rosenberg J., Lewis J. Drug-induced liver injury: Highlights of the recent literature. Drug Saf. 2019;42:365\u2013387. doi: 10.1007/s40264-018-0743-2.", "ArticleIdList": ["10.1007/s40264-018-0743-2", "30343418"]}, {"Citation": "Danan G., Teschke R. RUCAM in drug and herb induced liver injury: The update. Int. J. Mol. Sci. 2016;17:14. doi: 10.3390/ijms17010014.", "ArticleIdList": ["10.3390/ijms17010014", "PMC4730261", "26712744"]}, {"Citation": "Danan G., Teschke R. Drug-induced liver injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) still used 25 years after its launch? Drug Saf. 2018;41:735\u2013743. doi: 10.1007/s40264-018-0654-2.", "ArticleIdList": ["10.1007/s40264-018-0654-2", "29502198"]}, {"Citation": "Hennes E.M., Zeniya M., Czaja A.J., Par\u00e9s A., Dalekos G.N., Krawitt E.L., Bittencourt P.L., Porta G., Boberg K.M., Hofer H., et al. International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u2013176. doi: 10.1002/hep.22322.", "ArticleIdList": ["10.1002/hep.22322", "18537184"]}, {"Citation": "Yang X., Salminen W.F., Schnackenberg L.K. Current and emerging biomarkers of hepatotoxicity. Curr. Biomark. Find. 2012;2:43\u201355."}, {"Citation": "Senior J.R. Editorial. New biomarkers for drug-induced liver injury: Are they really better? What do they diagnose? Liver Int. 2014;34:325\u2013327. doi: 10.1111/liv.12384.", "ArticleIdList": ["10.1111/liv.12384", "25839081"]}, {"Citation": "Liu Y., Li P., Liu L., Zhang Y. The diagnostic role of miR-122 in drug-induced liver injury. A systematic review and meta-analysis. Medicine. 2018;97:49. doi: 10.1097/MD.0000000000013478.", "ArticleIdList": ["10.1097/MD.0000000000013478", "PMC6310488", "30544438"]}, {"Citation": "Teschke R., Schulze J., Eickhoff A., Danan G. Drug induced liver injury: Can biomarkers assist RUCAM in causality assessment? Special issue: Molecular Research on Drug Induced Liver Injury. Int. J. Mol. Sci. 2017;18:803. doi: 10.3390/ijms18040803.", "ArticleIdList": ["10.3390/ijms18040803", "PMC5412387", "28398242"]}, {"Citation": "Kumana C.R., Ng M., Lin H.J., Ko W., Wu P.C., Todd D. Herbal tea induced hepatic veno-occlusive disease: Quantification of toxic alkaloid exposure in adults. Gut. 1985;26:101\u2013104. doi: 10.1136/gut.26.1.101.", "ArticleIdList": ["10.1136/gut.26.1.101", "PMC1432401", "3965360"]}, {"Citation": "Teschke R., Larrey D., Melchart D., Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines. 2016;3:18. doi: 10.3390/medicines3030018.", "ArticleIdList": ["10.3390/medicines3030018", "PMC5456249", "28930128"]}, {"Citation": "Teschke R. Idiosyncratic DILI: Analysis of 46,266 cases assessed for causality by RUCAM and published from 2014 to early 2019. Front. Pharmacol. 2019;10:730. doi: 10.3389/fphar.2019.00730.", "ArticleIdList": ["10.3389/fphar.2019.00730", "PMC6664244", "31396080"]}, {"Citation": "Plourde G. Biomarkers in health product development: Commentary. Int. J. Drug Saf. 2018;2:2."}, {"Citation": "Davis M.A., Eldridge S., Louden C. In: Handbook of Toxicologic Pathology. 3rd ed. Haschek W., Rousseaux C., editors. Elsevier Corp.; Amsterdam, The Netherlands: 2013."}, {"Citation": "Teschke R., Danan G. Review: Drug induced liver injury with analysis of alternative causes as confounding variables. Br. J. Clin. Pharmacol. 2018;84:1467\u20131477. doi: 10.1111/bcp.13593.", "ArticleIdList": ["10.1111/bcp.13593", "PMC6005631", "29607530"]}, {"Citation": "Danan G., B\u00e9nichou C. Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J. Clin. Epidemiol. 1993;46:1323\u20131330. doi: 10.1016/0895-4356(93)90101-6.", "ArticleIdList": ["10.1016/0895-4356(93)90101-6", "8229110"]}, {"Citation": "B\u00e9nichou C., Danan G., Flahault A. Causality assessment of adverse reactions of drugs\u2014II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. J. Clin. Epidemiol. 1993;46:1331\u20131336. doi: 10.1016/0895-4356(93)90102-7.", "ArticleIdList": ["10.1016/0895-4356(93)90102-7", "8229111"]}, {"Citation": "Danan G., Teschke R. Roussel Uclaf Causality Assessment Method for drug-induced liver injury. Front. Pharmacol. 2019;10:853. doi: 10.3389/fphar.2019.00853.", "ArticleIdList": ["10.3389/fphar.2019.00853", "PMC6680600", "31417407"]}, {"Citation": "Church R., Watkins P.B. Serum biomarkers of drug-induced liver injury: Current status and future directions. J. Dig. Dis. 2019;20:2\u201310. doi: 10.1111/1751-2980.12684.", "ArticleIdList": ["10.1111/1751-2980.12684", "30378260"]}, {"Citation": "Fontana R.J. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914\u2013928. doi: 10.1053/j.gastro.2013.12.032.", "ArticleIdList": ["10.1053/j.gastro.2013.12.032", "PMC4031195", "24389305"]}, {"Citation": "Antoine D.J. Translational and mechanistic biomarkers of drug-induced liver injury\u2013Candidates and qualification strategies. In: Chen M., Will Y., Kang J., Casey D.C., editors. Drug-Induced Liver Toxicity. Springer; Berlin, Germany: 2018. (Series: Methods in Pharmacology and Toxicology/Y).", "ArticleIdList": ["10.1007/978-1-4939-7677-5_26"]}, {"Citation": "Krauskopf J., Kleinjans J.C., de Kok T.M. Circulating microRNAs as novel biomarkers of drug-induced liver injury in humans. In: Chen M., Will Y., Kang J., Casey D.C., editors. Drug-Induced Liver Toxicity. Springer; Berlin, Germany: 2018. pp. 597\u2013610. (Series: Methods in Pharmacology and Toxicology/Y). Chapter 28.", "ArticleIdList": ["10.1007/978-1-4939-7677-5_28"]}, {"Citation": "McGill M.R., Jaeschke H. MicroRNAs as signaling mediators and biomarkers of drug-and chemical-induced liver injury. J. Clin. Med. 2015;4:1063\u20131078. doi: 10.3390/jcm4051063.", "ArticleIdList": ["10.3390/jcm4051063", "PMC4470217", "26167291"]}, {"Citation": "Shi Q., Hong H., Senior J., Tong W. Biomarkers for drug-induced liver injury. Expert Rev. Gastroenterol. Hepatol. 2014;4:225\u2013234. doi: 10.1586/egh.10.8.", "ArticleIdList": ["10.1586/egh.10.8", "20350268"]}, {"Citation": "Enache L.S., Enache E.L., Rami\u00e8re C., Diaz O., Bancu L., Sin A., Andr\u00e9 Circulating RNA molecules as biomarkers in liver disease. Int. J. Mol. Sci. 2014;15:17644\u201317666. doi: 10.3390/ijms151017644.", "ArticleIdList": ["10.3390/ijms151017644", "PMC4227182", "25272224"]}, {"Citation": "Li L.M., Wang D., Zen K. Micro RNAs in drug-induced liver injury. Clin. Transl. Hepatol. 2014;2:162\u2013169. doi: 10.1016/j.cgh.2013.09.045.", "ArticleIdList": ["10.1016/j.cgh.2013.09.045", "PMC4521241", "26357624"]}, {"Citation": "Thulin P., Nordahl G., Gry M., Yimer G., Aklillu E., Makonnen E., Aderaye G., Lindquist L., Mattsson C.M., Kblom B.E., et al. Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts. Liver Int. 2014;34:367\u2013378. doi: 10.1111/liv.12322.", "ArticleIdList": ["10.1111/liv.12322", "24118944"]}, {"Citation": "Dragoi D., Benesic A., Pichler G., Kullak N.A., Bartsch H.S., Gerbes A.L. Proteomics analysis of monocyte-derived hepatocyte\u2013like cells identifies Integrin beta 3 as a specific biomarker for drug-induced liver injury by diclofenac. Front. Pharmacol. 2018;9:69931. doi: 10.3389/fphar.2018.00699.", "ArticleIdList": ["10.3389/fphar.2018.00699", "PMC6039575", "30022949"]}, {"Citation": "Tajima S., Yamamoto N., Masuda S. Commentary. Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy. Biochem. Pharmacol. 2019;170:113664. doi: 10.1016/j.bcp.2019.113664.", "ArticleIdList": ["10.1016/j.bcp.2019.113664", "31606409"]}, {"Citation": "Teschke R., Danan G. Causality assessment methods in drug-induced liver injury. In: Chen M., Will Y., Kang J., Casey D.C., editors. Drug-Induced Liver Toxicity. Springer; Berlin, Germany: 2018. pp. 555\u2013594. (Series: Methods in Pharmacology and Toxicology/Y). Chapter 27.", "ArticleIdList": ["10.1007/978-1-4939-7677-5_27"]}, {"Citation": "Pholmoo N., Bunchorntavakul C. Chacteristics and outcomes of acetaminophen overdose and hepatotoxicity in Thailand. J. Clin. Transl. Hepatol. 2019;7:1\u20138. doi: 10.14218/JCTH.2018.00066.", "ArticleIdList": ["10.14218/JCTH.2018.00066", "PMC6609840", "31293913"]}, {"Citation": "Yoon E., Babar A., Choudhary M., Kutner M., Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: A comprehensive update. J. Clin. Transl. Hepatol. 2016;4:131\u2013142.", "ArticleIdList": ["PMC4913076", "27350943"]}, {"Citation": "Ramachandran A., Jaeschke H. Acetaminophen toxicity: Novel insights into mechanisms and future perspectives. Gene Expr. 2018;18:19\u201330. doi: 10.3727/105221617X15084371374138.", "ArticleIdList": ["10.3727/105221617X15084371374138", "PMC5885144", "29054140"]}, {"Citation": "Teschke R., Stutz G., Strohmeyer G. Increased paracetamol-induced hepatotoxicity after chronic alcohol consumption. Biochem. Biophys. Res. Commun. 1979;91:368\u2013374. doi: 10.1016/0006-291X(79)90628-4.", "ArticleIdList": ["10.1016/0006-291X(79)90628-4", "574767"]}, {"Citation": "Teschke R., Zhu Y. Paracetamol (acetaminophen), alcohol, and liver injury: Biomarkers, clinical issues, and experimental aspects. SL Pharmacol. Toxicol. 2018;1:113."}, {"Citation": "Bunchorntavakul C., Reddy K.R. Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and acute liver failure. Clin. Liver Dis. 2018;22:325\u2013346. doi: 10.1016/j.cld.2018.01.007.", "ArticleIdList": ["10.1016/j.cld.2018.01.007", "29605069"]}, {"Citation": "Teschke R. Acetaminophen syn. paracetamol: Acute liver injury and acute on chronic liver failure with case analysis and causality assessment using RUCAM. In: Pyrsopoulos N.T., editor. Acute and Acute on Chronic. Springer Nature; Cham, Switzerland: 2019."}, {"Citation": "Ganger D.R., Rule J., Rakela J., Bass N., Reuben A., Stravitz R.T., Sussman N., Larson A.M., James L., Chiu C., et al. Acute Liver Failure Study Group. Acute liver failure of indeterminate etiology: A comprehensive systematic approach by an expert committee to establish causality. Am. J. Gastroenterol. 2018;113:1319. doi: 10.1038/s41395-018-0160-2.", "ArticleIdList": ["10.1038/s41395-018-0160-2", "PMC9252260", "29946176"]}, {"Citation": "Moore A. Paracetamol: Widely Used and Largely Ineffective. Cochrane.  [(accessed on 16 October 2019)];2016  Available online:  https://uk.cochrane.org/news/paracetamol-widely-used-and-largely-ineffective."}, {"Citation": "Lee W.M. Acetaminophen (APAP) hepatotoxicity-isn\u2019t it time for APAP to go away? J. Hepatol. 2017;67:1324\u20131331. doi: 10.1016/j.jhep.2017.07.005.", "ArticleIdList": ["10.1016/j.jhep.2017.07.005", "PMC5696016", "28734939"]}, {"Citation": "Mikus M., Drobin K., Gry M., Bachmann J., Lindberg J., Yimer G., Aklillu E., Makonnen E., Aderaye G., Roach J., et al. Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury. Liver Int. 2017;37:132\u2013140. doi: 10.1111/liv.13174.", "ArticleIdList": ["10.1111/liv.13174", "PMC5215406", "27224670"]}, {"Citation": "Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. USA. 2009;106:4402\u20134407. doi: 10.1073/pnas.0813371106.", "ArticleIdList": ["10.1073/pnas.0813371106", "PMC2657429", "19246379"]}, {"Citation": "Lewis P.J.S., Dear J., Platt V., Simpson K.J., Craig D.G.N., Antoine D.J., French N.S., Dhaun N., Webb D.J., Costello E.M., et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology. 2011;54:1767\u20131776. doi: 10.1002/hep.24538.", "ArticleIdList": ["10.1002/hep.24538", "22045675"]}, {"Citation": "Robles-D\u00edaz M., Medina-Caliz I., Stephens C., Andrade R.J., Lucena M.I. Biomarkers in DILI: One more step forward. Front. Pharmacol. 2016;7:267. doi: 10.3389/fphar.2016.00267.", "ArticleIdList": ["10.3389/fphar.2016.00267", "PMC4992729", "27597831"]}, {"Citation": "Iorga A., Dara L., Kaplowitz N. Drug-induced liver injury: Cascade of events leading to cell death, apoptosis or necrosis. Int. J. Mol. Sci. 2017;18:1018. doi: 10.3390/ijms18051018.", "ArticleIdList": ["10.3390/ijms18051018", "PMC5454931", "28486401"]}, {"Citation": "Vliegenthart A.D.B., Berends C., Potter C.M.J., Kersaudy-Kerhoas M., Dear J.W. MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury. Br. J. Clin. Pharmacol. 2017;83:2027\u20132033. doi: 10.1111/bcp.13282.", "ArticleIdList": ["10.1111/bcp.13282", "PMC5555871", "28257154"]}, {"Citation": "Roberts D.W., Lee W.M., Hinson J.A., Bai S., Swearingen C.J., Stravitz R.T., Reuben A., Letzig L., Simpson P.M., Rule J., et al. An immunoassay to rapidly measure acetaminophen protein adducts accurately identifies patients with acute liver injury or failure. Clin. Gastroenterol. Hepatol. 2017;15:555\u2013562. doi: 10.1016/j.cgh.2016.09.007.", "ArticleIdList": ["10.1016/j.cgh.2016.09.007", "PMC5528860", "27641661"]}, {"Citation": "Heard K., Anderson V., Dart R. Serum acetaminophen protein adduct concentrations in pediatric emergency department patients. Hepatology. 2017;64:533\u2013535. doi: 10.1097/MPG.0000000000001459.", "ArticleIdList": ["10.1097/MPG.0000000000001459", "27846064"]}, {"Citation": "Wong A., Graudins A. Risk prediction of hepatotoxicity in paracetamol poisoning. Clin. Toxicol. 2017;55:879\u2013892. doi: 10.1080/15563650.2017.1317349.", "ArticleIdList": ["10.1080/15563650.2017.1317349", "28447858"]}, {"Citation": "Heard K., Anderson V., Lavonas E. Serum paracetamol-protein adduct concentrations in ambulatory subjects: Relationship to recent reported paracetamol use. Biomarkers. 2018;23:288\u2013292. doi: 10.1080/1354750X.2017.1410857.", "ArticleIdList": ["10.1080/1354750X.2017.1410857", "29179598"]}, {"Citation": "Kim J.W., Ryu S.H., Kim S., Lee H.W., Lim M.S., Seong S.J., Kim S., Yoon Y.R., Kim K.B. Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary 1H NMR-based metabolomics in humans. Anal. Chem. 2013;85:11326\u201311334. doi: 10.1021/ac402390q.", "ArticleIdList": ["10.1021/ac402390q", "24127682"]}, {"Citation": "Schnackenberg L.K., Sun J., Bhattacharyya S., Gill P., James L.P., Beger R.D. Metabolomics analysis of urine samples from children after acetaminophen overdose. Metabolites. 2017;7:46. doi: 10.3390/metabo7030046.", "ArticleIdList": ["10.3390/metabo7030046", "PMC5618331", "28878168"]}, {"Citation": "Suk K.T., Kim D.J., Kim C.H., Park S.H., Yoon J.H., Kim Y.S., Baik G., Kim J., Kweon Y., Kim S.H., et al. A prospective nationwide study of drug-induced liver injury in Korea. Am. J. Gastroenterol. 2012;107:1380\u20131387. doi: 10.1016/j.bbrc.2018.02.030.", "ArticleIdList": ["10.1016/j.bbrc.2018.02.030", "22733303"]}, {"Citation": "Jing J., Teschke R. Traditional Chinese medicine (TCM) and herb induced liver injury: Comparison with drug induced liver injury. J. Clin. Transl. Hepatol. 2018;6:1\u201312. doi: 10.14218/JCTH.2017.00033.", "ArticleIdList": ["10.14218/JCTH.2017.00033", "PMC5863000", "29577033"]}, {"Citation": "Wai C.T., Tan B.H., Chan C.L., Sutedja D.S., Lee Y.M., Khor C., Lim S.G. Drug-induced liver injury at an Asian center: A prospective study. Liver Int. 2007;27:465\u2013474. doi: 10.1111/j.1478-3231.2007.01461.x.", "ArticleIdList": ["10.1111/j.1478-3231.2007.01461.x", "17403186"]}, {"Citation": "Lin N.H., Yang H.W., Su Y.J., Chang C.W. Herb induced liver injury after using herbal medicine. A systemic review and case-control study. Medicine. 2019;98:e14992. doi: 10.1097/MD.0000000000014992.", "ArticleIdList": ["10.1097/MD.0000000000014992", "PMC6456154", "30921214"]}, {"Citation": "Brown A.C. Invited review. Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series. Food Chem. Toxicol. 2017;107:472\u2013501. doi: 10.1016/j.fct.2016.07.001.", "ArticleIdList": ["10.1016/j.fct.2016.07.001", "27402097"]}, {"Citation": "Teschke R., Eickhoff A., Wolff A., Xuan T.D. Liver injury from herbs and \u201cdietary supplements\u201d: Highlights of a literature review from 2015 to 2017. Curr. Pharmacol. Rep. 2018;4:120\u2013131. doi: 10.1007/s40495-018-0124-7.", "ArticleIdList": ["10.1007/s40495-018-0124-7"]}, {"Citation": "Teschke R., Danan G. Causality assessment in pharmacovigilance for herbal medicines. In: Barnes J., editor. Pharmacovigilance of Herbal Medicines: Reflections, Solutions and Future Perspectives. Springer; Amsterdam, The Netherlands: 2019. Invited Book Chapter; Adis Books."}, {"Citation": "Wang J.B., Zhu Y., Bai Z.F., Wang F.S., Li X.H., Xiao X.H., on behalf of The Branch Committee for Hepatobiliary Diseases and Branch Committee for Chinese Patent Medicines, China Association of Chinese Medicine Guidelines for the diagnosis and management of herb-induced liver injury. Chin. J. Integr. Med. 2018;24:696\u2013706. doi: 10.1007/s11655-018-3000-8.", "ArticleIdList": ["10.1007/s11655-018-3000-8", "29542018"]}, {"Citation": "Yu Y.C., Mao Y.M., Chen C.W., Chen J.J., Chen J., Cong W.M., Ding Y., Duan Z.P., Fu Q.C., Guo X.Y., et al. CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol. Int. 2017;11:221\u2013241. doi: 10.1007/s12072-017-9793-2.", "ArticleIdList": ["10.1007/s12072-017-9793-2", "PMC5419998", "28405790"]}, {"Citation": "Teschke R., Xuan T.D. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment. Jpn. J. Gastroenterol. Hepatol. 2019;1:1\u201316."}, {"Citation": "Wang J., Ma Z., Niu M., Zhu Y., Liang Q., Zhao Y., Song J., Bai Z., Zhang Y., Zhang P., et al. Evidence chain-based causality identification in herb-induced liver injury: Exemplification of a well-known liver-restorative herb Polygonum multiflorum. Front. Med. 2015;9:457\u2013467. doi: 10.1007/s11684-015-0417-8.", "ArticleIdList": ["10.1007/s11684-015-0417-8", "26459430"]}, {"Citation": "Jing J., Wang R.L., Zhao X.Y., Zhu Y., Niu M., Wang L.F., Song X.A., He T.T., Sun Y.Q., Xu W.T., et al. Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb-Polygonum multiflorum thunb. induced liver injury: A case-control study from a specialised liver disease center in China. BMJ Open. 2019;9:e023567. doi: 10.1136/bmjopen-2018-023567.", "ArticleIdList": ["10.1136/bmjopen-2018-023567", "PMC6340630", "30782709"]}, {"Citation": "Melchart D., Hager S., Albrecht S., Dai J., Weidenhammer W., Teschke R. Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study. World J. Hepatol. 2017;9:1141\u20131157. doi: 10.4254/wjh.v9.i29.1141.", "ArticleIdList": ["10.4254/wjh.v9.i29.1141", "PMC5648988", "29085558"]}, {"Citation": "Zhu Y., Niu M., Chen J., Zou Z.S., Ma Z.J., Liu S.H., Wang R.L., He T.T., Song H.B., Wang Z.X., et al. Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J. Gastroenterol. Hepatol. 2016;31:1476\u20131482. doi: 10.1111/jgh.13323.", "ArticleIdList": ["10.1111/jgh.13323", "26896664"]}, {"Citation": "Zhang P., Ye Y., Yang X., Jiao Y. Systematic review on Chinese herbal medicine induced liver injury. Evid. Based Complement. Alternat. Med. 2016;2016:15. doi: 10.1155/2016/3560812.", "ArticleIdList": ["10.1155/2016/3560812", "PMC5019919", "27651817"]}, {"Citation": "Wang R., Qi X., Yoshida E.M., M\u00e9ndez-S\u00e1nchez N., Teschke R., Sun M., Liu X., Su C., Deng J., Deng H., et al. Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: A systematic review. Exp. Rev. Gastroenterol. Hepatol. 2018;12:425\u2013434. doi: 10.1080/17474124.2018.1427581.", "ArticleIdList": ["10.1080/17474124.2018.1427581", "29323538"]}, {"Citation": "Zhu Y., Niu M., Wang J.B., Wang R.L., Li J.Y., Ma Y.Q., Zhao Y.L., Zhang Y.F., He T.T., Yu S.M., et al. Predictors of poor outcomes in 488 patients with herb-induced liver injury. Turk. J. Gastroenterol. 2019;30:47\u201358. doi: 10.5152/tjg.2018.17847.", "ArticleIdList": ["10.5152/tjg.2018.17847", "PMC6389292", "30289391"]}, {"Citation": "Meunier L., Larrey D. DILI: Biomarkers, requirements, candidates and validation. Front. Pharmacol. 2019;10:1482. doi: 10.3389/fphar.2019.01482.", "ArticleIdList": ["10.3389/fphar.2019.01482", "PMC6917655", "31920666"]}, {"Citation": "Larrey D., Faure S. Herbal medicine hepatotoxicity: A new step with development of specific biomarkers. J. Hepatol. 2011;54:599\u2013601. doi: 10.1016/j.jhep.2010.12.003.", "ArticleIdList": ["10.1016/j.jhep.2010.12.003", "21167851"]}, {"Citation": "Larrey D., Vial T., Pauwels A., Castot A., Biour M., David M., Michel H. Hepatitis after germander (Teucrium chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann. Intern. Med. 1992;117:129\u2013132. doi: 10.7326/0003-4819-117-2-129.", "ArticleIdList": ["10.7326/0003-4819-117-2-129", "1605427"]}, {"Citation": "Loeper J., Descatoire V., Letteron P., Moulis C., Degott C., Dansette P., Fau D., Pessayre D. Hepatotoxicity of germander in mice. Gastroenterology. 1994;106:464\u2013472. doi: 10.1016/0016-5085(94)90606-8.", "ArticleIdList": ["10.1016/0016-5085(94)90606-8", "8299912"]}, {"Citation": "Fau D., Lekehal M., Farrell G., Moreau A., Moulis C., Feldman G., Haouzi D., Pessayre D. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology. 1997;117:1334\u20131336. doi: 10.1053/gast.1997.v113.pm9322529.", "ArticleIdList": ["10.1053/gast.1997.v113.pm9322529", "9322529"]}, {"Citation": "Frenzel C., Teschke R. Herbal hepatotoxicity: Clinical characteristics and listing compilation. Int. J. Mol. Sci. 2016;17:588. doi: 10.3390/ijms17050588.", "ArticleIdList": ["10.3390/ijms17050588", "PMC4881436", "27128912"]}, {"Citation": "Li Y.X., Gong X.H., Liu M.C., Peng C., Li P., Wang Y.T. Investigation of liver injury of Polygonum multiflorum Thunb. in rats by metabolomics and traditional approaches. Front. Pharmacol. 2017;8:791. doi: 10.3389/fphar.2017.00791.", "ArticleIdList": ["10.3389/fphar.2017.00791", "PMC5672018", "29163173"]}, {"Citation": "Gao H., Li N., Wang J.Y., Zhang S.C., Lin G. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J. Dig. Dis. 2012;13:33\u201339. doi: 10.1111/j.1751-2980.2011.00552.x.", "ArticleIdList": ["10.1111/j.1751-2980.2011.00552.x", "22188914"]}, {"Citation": "Wang J.Y., Gao H. Tusanqi and hepatic sinusoidal obstruction syndrome. Dig. Dis. 2014;15:105\u2013107. doi: 10.1111/1751-2980.12112.", "ArticleIdList": ["10.1111/1751-2980.12112", "24528632"]}, {"Citation": "Teschke R., Eickhoff A., Schulze J., Wolff A., Frenzel C., Melchart D. Petadolex\u00ae, a herbal extract for migraine prophylaxis with spontaneous case reports of disputed liver injury: Robust causality evaluation by RUCAM, the Roussel Uclaf Causality Assessment Method. Eur. J. Pharm. Med. Res. 2016;3:154\u2013177."}, {"Citation": "Teschke R., Wolff A., Frenzel C., Schulze J., Eickhoff A. Herbal hepatotoxicity: A tabular compilation of reported cases. Liver Int. 2012;32:1543\u20131556. doi: 10.1111/j.1478-3231.2012.02864.x.", "ArticleIdList": ["10.1111/j.1478-3231.2012.02864.x", "22928722"]}, {"Citation": "Teschke R., Schwarzenboeck A., Eickhoff A., Frenzel C., Wolff A., Schulze J. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin. Drug Saf. 2013;12:339\u2013366. doi: 10.1517/14740338.2013.774371.", "ArticleIdList": ["10.1517/14740338.2013.774371", "23458441"]}, {"Citation": "Teschke R. Traditional Chinese Medicine induced liver injury. J. Clin. Transl. Hepatol. 2014;2:80\u201394. doi: 10.14218/JCTH.2014.00003.", "ArticleIdList": ["10.14218/JCTH.2014.00003", "PMC4521264", "26357619"]}, {"Citation": "Teschke R., Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine: Actual key issues and new encouraging steps. Front. Pharmacol. 2015;6:72. doi: 10.3389/fphar.2015.00072.", "ArticleIdList": ["10.3389/fphar.2015.00072", "PMC4407580", "25954198"]}, {"Citation": "Teschke R., Zhang L., Long H., Schwarzenboeck A., Schmidt-Taenzer W., Genthner A., Wolff A., Frenzel C., Schulze J., Eickhoff A. Traditional Chinese Medicine and herbal hepatotoxicity: A tabular compilation of reported cases. Ann. Hepatol. 2015;14:7\u201319. doi: 10.1016/S1665-2681(19)30796-3.", "ArticleIdList": ["10.1016/S1665-2681(19)30796-3", "25536637"]}, {"Citation": "Teschke R., Zhang L. Chinese herbs and their molecules: Clinical and pathophysiological implications for the liver. J. Mol. Pathophysiol. 2015;4:85\u201392. doi: 10.5455/jmp.20150710032817.", "ArticleIdList": ["10.5455/jmp.20150710032817"]}, {"Citation": "Zhu Y., Liu S.H., Wang J.B., Song H.B., Li Y.G., He T.T., Ma X., Wang Z.X., Wang L.P., Zhou K., et al. Clinical analysis of drug-induced liver injury caused by Polygonum multiflorum and its preparations. Chin. J. Integr. Tradit. West. Med. 2015;35:1442\u20131447. (Abstract In English, Article In Chinese)", "ArticleIdList": ["26882605"]}, {"Citation": "Neuman M.G., Cohen L.B., Opris M., Nanau R., Jeong H. Pyrrolizidine alkaloids induced hepatotoxicity. J. Pharm. Pharm. Sci. 2015;18:825\u2013843. doi: 10.18433/J3BG7J.", "ArticleIdList": ["10.18433/J3BG7J", "26626258"]}, {"Citation": "Lin G., Wang J.Y., Li N., Li M., Gao H., Ji Y., Zhang F., Wang H., Zhou Y., Ye Y., et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J. Hepatol. 2011;54:666\u2013673. doi: 10.1016/j.jhep.2010.07.031.", "ArticleIdList": ["10.1016/j.jhep.2010.07.031", "21146894"]}, {"Citation": "Zhu J., Seo J.E., Wang S., Ashby K., Ballard R., Yu D., Ning B., Agarwal R., Borlak J., Tong W., et al. The development of a database for herbal and dietary supplement induced liver toxicity. Int. J. Mol. Sci. 2018;19:2955. doi: 10.3390/ijms19102955.", "ArticleIdList": ["10.3390/ijms19102955", "PMC6213387", "30274144"]}, {"Citation": "Teschke R., Schulze J., Schwarzenboeck A., Eickhoff A., Frenzel C. Herbal hepatotoxicity: Suspected cases assessed for alternative causes. Eur. J. Gastroenterol. Hepatol. 2013;25:1093\u20131098. doi: 10.1097/MEG.0b013e3283603e89.", "ArticleIdList": ["10.1097/MEG.0b013e3283603e89", "23510966"]}, {"Citation": "Teschke R., Bahre R., Genthner A., Fuchs J., Schmidt-Taenzer W., Wolff A. Suspected black cohosh hepatotoxicity-Challenges and pitfalls of causality assessment. Maturitas. 2009;63:302\u2013314. doi: 10.1016/j.maturitas.2009.05.006.", "ArticleIdList": ["10.1016/j.maturitas.2009.05.006", "19586731"]}, {"Citation": "Teschke R. Black cohosh and suspected hepatotoxicity-inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm: A critical review. Menopause. 2010;17:426\u2013440. doi: 10.1097/gme.0b013e3181c5159c.", "ArticleIdList": ["10.1097/gme.0b013e3181c5159c", "20216279"]}, {"Citation": "Teschke R., Frenzel C., Wolff A., Herzog J., Glass X., Schulze J., Eickhoff A. Initially purported hepatotoxicity by Pelargonium sidoides: The dilemma of pharmacovigilance and proposals for improvements. Ann. Hepatol. 2012;11:500\u2013512. doi: 10.1016/S1665-2681(19)31464-4.", "ArticleIdList": ["10.1016/S1665-2681(19)31464-4", "22700632"]}, {"Citation": "Teschke R., Frenzel C., Schulze J., Schwarzenboeck A., Eickhoff A. Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests. World J. Hepatol. 2013;5:353\u2013363. doi: 10.4254/wjh.v5.i7.353.", "ArticleIdList": ["10.4254/wjh.v5.i7.353", "PMC3724963", "23898368"]}, {"Citation": "Teschke R., Genthner A., Wolff A., Frenzel C., Schulze J., Eickhoff A. Herbal hepatotoxicity: Analysis of cases with initially reported positive reexposure tests. Dig. Liver Dis. 2014;46:264\u2013269. doi: 10.1016/j.dld.2013.10.020.", "ArticleIdList": ["10.1016/j.dld.2013.10.020", "24315480"]}, {"Citation": "Teschke R., Schwarzenboeck A., Frenzel C., Schulze J., Eickhoff A., Wolff A. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann. Hepatol. 2016;15:91\u2013119. doi: 10.5604/16652681.1184237.", "ArticleIdList": ["10.5604/16652681.1184237", "26626645"]}, {"Citation": "Teschke R., Eickhoff A. The Honolulu Liver disease cluster at the Medical Center: Its mysteries and challenges. Int. J. Mol. Sci. 2016;17:476. doi: 10.3390/ijms17040476.", "ArticleIdList": ["10.3390/ijms17040476", "PMC4848932", "27043544"]}, {"Citation": "Teschke R., Wolff A., Frenzel C., Eickhoff A., Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J. Gastroenterol. 2015;21:4466\u20134490. doi: 10.3748/wjg.v21.i15.4466.", "ArticleIdList": ["10.3748/wjg.v21.i15.4466", "PMC4402294", "25914456"]}, {"Citation": "WHO  . Global Status Report on Alcohol and Health. World Health Organization; Geneva, Switzerland: 2011.  [(accessed on 20 October 2019)].  Available online:  https://www.who.int/substance_abuse/publications/alcohol_2011/en/"}, {"Citation": "Rehm J., Samokhvalov A.V., Shield K.D. Global burden of alcoholic liver diseases. J. Hepatol. 2013;59:160\u2013168. doi: 10.1016/j.jhep.2013.03.007.", "ArticleIdList": ["10.1016/j.jhep.2013.03.007", "23511777"]}, {"Citation": "Salaspuro M. Epidemiological aspects of alcohol and alcoholic liver disease, ethanol metabolism, and pathogenesis of alcoholic liver injury. Oxf. Textb. Clin. Hepatol. 1991;2:791\u2013810."}, {"Citation": "Neuman M.G., French S.W., French B.A., Seitz H.K., Cohen L.B., Mueller S., Osna N.A., Kharbanda K.K., Seth D., Bautista A., et al. Alcoholic and non-alcoholic steatohepatitis. Exp. Mol. Pathol. 2014;97:492\u2013510. doi: 10.1016/j.yexmp.2014.09.005.", "ArticleIdList": ["10.1016/j.yexmp.2014.09.005", "PMC4696068", "25217800"]}, {"Citation": "Seitz H.K., Bataller R., Cortez-Pinto H., Gao B., Gual A., Lackner C., Mathurin P., Mueller S., Szabo G., Tsukamoto H. Alcoholic liver disease. Nat. Rev. Dis. Prim. 2018;4:16. doi: 10.1038/s41572-018-0014-7.", "ArticleIdList": ["10.1038/s41572-018-0014-7", "30115921"]}, {"Citation": "Osna N.A., Donohue T.M., Kharbanda K.K. Alcoholic liver disease: Pathogenesis and current management. Alcohol. Res. 2017;38:147\u2013161.", "ArticleIdList": ["PMC5513682", "28988570"]}, {"Citation": "Pimpin L., Cortez-Pinto H., Negro F., Corbould E., Lazarus J.V., Webber L., Sheron N. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. J. Hepatol. 2018;69:718\u2013735. doi: 10.1016/j.jhep.2018.05.011.", "ArticleIdList": ["10.1016/j.jhep.2018.05.011", "29777749"]}, {"Citation": "Neuman M.G., French S.W., Zakhari S., Malnick S., Seitz H.K., Cohen L.B., Salaspuro M., Voinea-Griffin A., Barasch A., Kirpich I.A., et al. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Exp. Mol. Pathol. 2017;102:162\u2013180. doi: 10.1016/j.yexmp.2017.01.003.", "ArticleIdList": ["10.1016/j.yexmp.2017.01.003", "28077318"]}, {"Citation": "Bergheim I., McClain C., Arteel G.E. Treatment of alcoholic liver disease. Dig. Dis. 2005;23:275\u2013284. doi: 10.1159/000090175.", "ArticleIdList": ["10.1159/000090175", "PMC2636549", "16508292"]}, {"Citation": "Mathurin P., Lucey M.R. Management of alcoholic hepatitis. J. Hepatol. 2012;56:S39\u2013S45. doi: 10.1016/S0168-8278(12)60005-1.", "ArticleIdList": ["10.1016/S0168-8278(12)60005-1", "22300464"]}, {"Citation": "EASL  2010 Guidelines: Management of Alcoholic Liver Disease.  [(accessed on 15 October 2019)]; Available online:  http://www.easl.eu/research/our-contributions/clinical-practice-guidelines/detail/management-of-alcoholic-liver-disease-easl-clinical-practice-/report/1."}, {"Citation": "O\u2019Shea R.S., Dasarathy S., McCullough A.J. Alcoholic liver disease.  [(accessed on 15 October 2019)];Am. J. Gastroenterol. 2010 105:14\u201332. doi: 10.1038/ajg.2009.593. Available online:  https://www.ncbi.nlm.nih.gov/pubmed/19904248.", "ArticleIdList": ["10.1038/ajg.2009.593", "19904248"]}, {"Citation": "Teschke R. Alcoholic steatohepatitis (ASH) and acute alcoholic hepatitis (AH): Cascade of events, clinical features, and pharmacotherapy options. Exp. Opin. Pharmacother. 2018;19:779\u2013793. doi: 10.1080/14656566.2018.1465929.", "ArticleIdList": ["10.1080/14656566.2018.1465929", "29708448"]}, {"Citation": "Teschke R. Alcoholic liver disease: Alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects. Biomedicines. 2018;6:106. doi: 10.3390/biomedicines6040106.", "ArticleIdList": ["10.3390/biomedicines6040106", "PMC6316574", "30424581"]}, {"Citation": "Teschke R. Alcoholic liver disease: Current mechanistic aspects with focus on their clinical relevance. Biomedicines. 2019;7:68. doi: 10.3390/biomedicines7030068.", "ArticleIdList": ["10.3390/biomedicines7030068", "PMC6783919", "31491888"]}, {"Citation": "Sevastianos V.A., Dourakis S.P. Alcoholic liver disease: A clinical review. J. Nutr. Food Sci. 2016;6:508. doi: 10.4172/2155-9600.1000508.", "ArticleIdList": ["10.4172/2155-9600.1000508"]}, {"Citation": "Cohen J.A., Kaplan M.M. The SGOT/SGPT ratio an indicator of alcoholic liver disease. Dig. Dis. Sci. 1979;24:835\u2013838. doi: 10.1007/BF01324898.", "ArticleIdList": ["10.1007/BF01324898", "520102"]}, {"Citation": "Huang A., Chang B., Sun Y., Lin H., Li B., Teng G., Zou Z.S. Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013. Medicine. 2017;96:e6163. doi: 10.1097/MD.0000000000006163.", "ArticleIdList": ["10.1097/MD.0000000000006163", "PMC5319541", "28207552"]}, {"Citation": "Worner T.M., Lieber C.S. Plasma glutamate dehydrogenase: Clinical application in patients with alcoholic liver disease. Alcohol. Clin. Exp. Res. 1980;4:431\u2013434. doi: 10.1111/j.1530-0277.1980.tb04845.x.", "ArticleIdList": ["10.1111/j.1530-0277.1980.tb04845.x", "7004246"]}, {"Citation": "Van Waes L., Lieber C.S. Glutamate dehydrogenase: A reliable marker of liver cell necrosis in the alcoholic. Br. Med. J. 1977;2:1508\u20131510. doi: 10.1136/bmj.2.6101.1508.", "ArticleIdList": ["10.1136/bmj.2.6101.1508", "PMC1632812", "589307"]}, {"Citation": "Blaya D., Col M., Rodrigo-Torres D., Vila-Casades\u00fas M., Altamirano J., Llopis M., Graupera I., Perea L., Aguilar-Bravo B., D\u00edaz A., et al. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation. Gut. 2016;65:1535\u20131545. doi: 10.1136/gutjnl-2015-311314.", "ArticleIdList": ["10.1136/gutjnl-2015-311314", "27196584"]}, {"Citation": "Lieber C.S. Microsomal ethanol-oxidizing system (MEOS): The first 30 years (1968\u20131998)-A review. Alcohol. Clin. Exp. Res. 1999;2:991\u20131007. doi: 10.1097/00000374-199906000-00006.", "ArticleIdList": ["10.1097/00000374-199906000-00006", "10397283"]}, {"Citation": "Lieber C.S. Cytochrome P-4502E1: Its physiological and pathological role. Physiol. Rev. 1997;77:517\u2013544. doi: 10.1152/physrev.1997.77.2.517.", "ArticleIdList": ["10.1152/physrev.1997.77.2.517", "9114822"]}, {"Citation": "Teschke R. Microsomal ethanol-oxidizing system (MEOS): Success over 50 years and an encouraging future. Alcohol. Clin. Exp. Res. 2019;43:386\u2013400. doi: 10.1111/acer.13961.", "ArticleIdList": ["10.1111/acer.13961", "30667528"]}, {"Citation": "Cederbaum A.I. Microsomal generation of hydroxyl radicals: Its role in microsomal ethanol oxidizing system (MEOS) activity and requirement of iron. Ann. N. Y. Acad. Sci. 1987;492:35\u201349. doi: 10.1111/j.1749-6632.1987.tb48651.x.", "ArticleIdList": ["10.1111/j.1749-6632.1987.tb48651.x", "3037964"]}, {"Citation": "Teschke R. Biochemical aspects of the hepatic microsomal ethanol-oxidizing system (MEOS): Resolved initial controversies and updated molecular views. Biochem. Pharmacol. 2019;8:267. doi: 10.35248/2167-0501.19.8.267.", "ArticleIdList": ["10.35248/2167-0501.19.8.267"]}, {"Citation": "Lieber C.S., DeCarli L.M., Matsuzaki S., Ohnishi K., Teschke R. The microsomal ethanol-oxidizing system. In: Fleischer S., Packer L., editors. Methods in Enzymology. Academic Press; New York, NY, USA: 1978. pp. 355\u2013368.", "ArticleIdList": ["97494"]}, {"Citation": "Cho Y.E., Mezey E., Hardwick J.P., Salem N., Clemens D.L., Song B.J. Increased ethanol-inducible cytochrome P450-2E1 and cytochrome P450 isoforms in exosomes of alcohol-exposed rodents and patients with alcoholism through oxidative and endoplasmic reticulum stress. Hepatol. Commun. 2017;1:675\u2013690. doi: 10.1002/hep4.1066.", "ArticleIdList": ["10.1002/hep4.1066", "PMC5721437", "29404485"]}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "12", "Day": "2"}, {"Year": "2019", "Month": "12", "Day": "21"}, {"Year": "2019", "Month": "12", "Day": "23"}, {"Year": "2020", "Month": "1", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31892250", "PMC6981464", "10.3390/ijms21010212", "ijms21010212"]}}], "PubmedBookArticle": []}